• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.

作者信息

Zeidan Amer, Bolaños-Meade Javier, Kasamon Yvette, Aoki Joseph, Borowitz Michael, Swinnen Lode, Symons Heather, Luznik Leo, Fuchs Ephraim, Jones Richard, Ambinder Richard

出版信息

Leuk Lymphoma. 2013 Mar;54(3):655-7. doi: 10.3109/10428194.2012.717082. Epub 2012 Aug 27.

DOI:10.3109/10428194.2012.717082
PMID:22845310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4234092/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0091/4234092/87e0d5511588/nihms-630896-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0091/4234092/87e0d5511588/nihms-630896-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0091/4234092/87e0d5511588/nihms-630896-f0001.jpg

相似文献

1
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.人类白细胞抗原半相合造血干细胞移植治疗组织细胞肉瘤患者
Leuk Lymphoma. 2013 Mar;54(3):655-7. doi: 10.3109/10428194.2012.717082. Epub 2012 Aug 27.
2
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.降低毒性的清髓性人类白细胞抗原半相合造血干细胞移植联合移植后环磷酰胺治疗镰状细胞病
Ann Hematol. 2017 Aug;96(8):1373-1377. doi: 10.1007/s00277-017-3030-x. Epub 2017 Jun 1.
3
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.自体与减低强度异基因造血细胞移植治疗首次完全缓解或部分缓解后化疗敏感的滤泡性非霍奇金淋巴瘤患者。
Biol Blood Marrow Transplant. 2011 Jul;17(7):1051-7. doi: 10.1016/j.bbmt.2010.11.004. Epub 2010 Nov 10.
4
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.阿仑单抗、氟达拉滨和美法仑减低剂量预处理造血细胞移植治疗非恶性疾病患者的经验显示疗效良好，且混合嵌合体的风险取决于基础疾病、干细胞来源和阿仑单抗方案。
Biol Blood Marrow Transplant. 2015 Aug;21(8):1460-70. doi: 10.1016/j.bbmt.2015.04.009. Epub 2015 Apr 10.
5
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.异体造血干细胞移植中用阿仑单抗进行体内 T 细胞耗竭：再生障碍性贫血和 HLA 单倍体不合亲缘移植两项研究的联合结果。
Am J Hematol. 2013 Apr;88(4):294-300. doi: 10.1002/ajh.23392. Epub 2013 Feb 28.
6
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.同种异体造血细胞移植后原发性移植物失败患者行 1 天非清髓性挽救方案的结果。
Bone Marrow Transplant. 2012 May;47(5):700-5. doi: 10.1038/bmt.2011.158. Epub 2011 Aug 1.
7
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.采用白消安、氟达拉滨和抗胸腺细胞球蛋白的低强度预处理方案行 HLA 单倍体相合造血细胞移植治疗急性白血病和骨髓增生异常综合征。
Blood. 2011 Sep 1;118(9):2609-17. doi: 10.1182/blood-2011-02-339838. Epub 2011 Jun 28.
8
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.慢性肉芽肿病患者的低强度预处理和 HLA 匹配造血干细胞移植：一项前瞻性多中心研究。
Lancet. 2014 Feb 1;383(9915):436-48. doi: 10.1016/S0140-6736(13)62069-3. Epub 2013 Oct 23.
9
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.使用单倍体相合相关供者与人类白细胞抗原（HLA）匹配的同胞供者进行淋巴瘤的减低强度移植：国际血液和骨髓移植研究中心分析
J Clin Oncol. 2016 Sep 10;34(26):3141-9. doi: 10.1200/JCO.2015.66.3476. Epub 2016 Jun 6.
10
Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.在婴儿中使用减低强度预处理方案进行异基因造血干细胞移植：墨西哥一家机构的经验
Pediatr Hematol Oncol. 2008 Jan-Feb;25(1):39-47. doi: 10.1080/08880010701773621.

引用本文的文献

1
Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review.新型联合免疫靶向治疗伴滤泡性淋巴瘤的组织细胞肉瘤的长期缓解：病例报告及文献复习。
Int J Mol Sci. 2024 Jul 2;25(13):7293. doi: 10.3390/ijms25137293.
2
Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.病例报告：针对原发性组织细胞肉瘤伴噬血细胞性淋巴组织细胞增生症中验证的 PD-1 受体和遗传突变。
Front Immunol. 2023 Mar 8;14:1127599. doi: 10.3389/fimmu.2023.1127599. eCollection 2023.
3
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.曲美替尼对丝裂原活化蛋白激酶（MEK）的抑制作用以及伊马替尼对酪氨酸激酶的抑制作用在多灶性组织细胞肉瘤中的反应。
Haematologica. 2018 Jan;103(1):e39-e41. doi: 10.3324/haematol.2017.179150. Epub 2017 Nov 2.
4
Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation.采用克拉屈滨、大剂量阿糖胞苷、粒细胞集落刺激因子和米托蒽醌（CLAG-M方案）治疗肾移植后发生的多灶性组织细胞肉瘤，随后进行异基因造血干细胞移植取得成功。
Case Rep Hematol. 2015;2015:728260. doi: 10.1155/2015/728260. Epub 2015 Jun 8.
5
Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.采用剂量递增的CHOP方案加依托泊苷进行诱导化疗及前期巩固性自体移植成功治疗组织细胞肉瘤。
Int J Hematol. 2014 Nov;100(5):507-10. doi: 10.1007/s12185-014-1630-y. Epub 2014 Jul 26.

本文引用的文献

1
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.非血缘供者移植后经减低强度预处理：使用部分 HLA 错配相关骨髓或无关双脐血移植物的平行 2 期试验结果。
Blood. 2011 Jul 14;118(2):282-8. doi: 10.1182/blood-2011-03-344853. Epub 2011 Apr 28.
2
A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant.一例难治性儿童组织细胞肉瘤经放化疗及自体外周血干细胞移植成功治疗。
Leuk Lymphoma. 2011 Jul;52(7):1367-71. doi: 10.3109/10428194.2011.565840. Epub 2011 Mar 22.
3
Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.自体造血干细胞移植联合沙利度胺治疗组织细胞肉瘤：一例病例报告及文献复习
J Clin Oncol. 2011 Apr 1;29(10):e251-3. doi: 10.1200/JCO.2010.32.6603. Epub 2011 Jan 10.
4
High-dose cyclophosphamide for graft-versus-host disease prevention.大剂量环磷酰胺预防移植物抗宿主病。
Curr Opin Hematol. 2010 Nov;17(6):493-9. doi: 10.1097/MOH.0b013e32833eaf1b.
5
A case of hemolytic anemia and severe thrombocytopenia related to histiocytic sarcoma.一例与组织细胞肉瘤相关的溶血性贫血和严重血小板减少症。
Leuk Res. 2010 Sep;34(9):e257-8. doi: 10.1016/j.leukres.2010.03.041. Epub 2010 May 15.
6
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.使用氟达拉滨和阿仑单抗作为预处理方案进行挽救性移植治疗同种异体移植失败。
Bone Marrow Transplant. 2009 Mar;43(6):477-80. doi: 10.1038/bmt.2008.353. Epub 2008 Nov 3.
7
Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.沙利度胺用于造血干细胞移植后组织细胞肉瘤的治疗。
Am J Hematol. 2007 Oct;82(10):932-3. doi: 10.1002/ajh.20913.
8
Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163.组织细胞肉瘤：一项包括组织细胞标志物CD163的5例病例研究。
Mod Pathol. 2005 May;18(5):693-704. doi: 10.1038/modpathol.3800346.
9
[Allogeneic bone marrow transplantation for a patient with malignant histiocytosis].
Zhonghua Xue Ye Xue Za Zhi. 1997 Aug;18(8):395-6.
10
Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.结外组织细胞肉瘤：14例罕见上皮样恶性肿瘤的临床病理分析
Am J Surg Pathol. 2004 Sep;28(9):1133-44. doi: 10.1097/01.pas.0000131541.95394.23.